CS224239B1 - Method of preparing 6-substituted derivatives of 5-/2-mercapto-4-oxo-3,4-dihydropyrimidin-5-yl/pentanoic acid - Google Patents
Method of preparing 6-substituted derivatives of 5-/2-mercapto-4-oxo-3,4-dihydropyrimidin-5-yl/pentanoic acid Download PDFInfo
- Publication number
- CS224239B1 CS224239B1 CS485682A CS485682A CS224239B1 CS 224239 B1 CS224239 B1 CS 224239B1 CS 485682 A CS485682 A CS 485682A CS 485682 A CS485682 A CS 485682A CS 224239 B1 CS224239 B1 CS 224239B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- mercapto
- oxo
- dihydropyrimidin
- formula
- pentanoic acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 title 2
- 150000001875 compounds Chemical class 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 claims description 8
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 8
- -1 6-substituted 5- (2-mercapto-4-oxo-3,4-dihydropyrimidin-5-yl) pentanoic acid Chemical class 0.000 claims description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 239000012266 salt solution Substances 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 230000000340 anti-metabolite Effects 0.000 description 2
- 229940100197 antimetabolite Drugs 0.000 description 2
- 239000002256 antimetabolite Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- DENAJDGQVVFGRE-UHFFFAOYSA-N diethyl 2-acetylheptanedioate Chemical compound CCOC(=O)CCCCC(C(C)=O)C(=O)OCC DENAJDGQVVFGRE-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- AFRWBGJRWRHQOV-UHFFFAOYSA-N ethyl 5-bromopentanoate Chemical compound CCOC(=O)CCCCBr AFRWBGJRWRHQOV-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Vynález se týká způsobu výroby 6-substitučníoh derivátů kyseliny 5-(2-merkapto-4-oxo-3»4-dihydropyrimidin-5-yl) pentanové obecného vzorce I,The invention relates to a process for the preparation of 6-substituted 5- (2-mercapto-4-oxo-3,4-dihydropyrimidin-5-yl) pentanoic acid derivatives of the general formula I:
ĎĎ
(i) ve kterém R značí alkyl s 1 až 7 atomy uhlíku, benzyl, fenyl, p-tolyl nebo 3»4,5-trimethoxyfenylovou skupinu.(i) wherein R is C 1 -C 7 alkyl, benzyl, phenyl, p-tolyl or 3,4-trimethoxyphenyl.
Látky obecného vzorce I, o výše uvedeném významu R, lze považovat jednak za látky s antimetabolitním charakterem účinku a jednak za vhodné prekursory pro synthesu protinádorově účinných látek typu pyrimidinových antimetabolitů. Analogicky mohou být využitelné k synthese látek s anti bakteriálním, protivirovým a int erferonogenním účinkem.The compounds of formula (I), as defined above for R, can be considered both to have antimetabolite activity and to be suitable precursors for the synthesis of antitumor agents of the pyrimidine antimetabolite type. Analogously, they can be used for the synthesis of substances with anti-bacterial, antiviral and intraferonogenic activity.
Látky obecného vzorce I, o výše uvedeném významu R, jsou látky dosud nepopsané. Lze je však připravit obecnými postupy pro synthesy derivátů pyrimidinu.The compounds of formula (I), as defined above for R, are as yet unwritten. However, they can be prepared by general procedures for the synthesis of pyrimidine derivatives.
Podle vynálezu se látky obecného vzorce I, o výše uvedeném významu R, připravují kondensací látek obecného vzorce II,According to the invention, the compounds of the formula I, as defined above, are prepared by condensation of the compounds of the formula II,
(II)Z (Ii) from
- 2 ve kterém R má stejný význam jako v obecném vzorci I, s 2 až 5 molekvivalenty thiomočoviny, výhodně s 3 molekvivalenty, v přítomnosti 3 molekvivalentů methylátu sodného, v rozmezí teplot od 20 °C až do teploty varu reakční směsi, načež se kondensát zmýdelní působením vodného roztoku hydroxidu sodného při teplotě 20 až 25 °C, a látky obecného vzorce I, o výše uvedeném významu R se uvolní z roztoku sodné soli působením minerální kyseliny.Wherein R has the same meaning as in formula I, with 2 to 5 mol equivalents of thiourea, preferably 3 mol equivalents, in the presence of 3 mol equivalents of sodium methylate, in the temperature range of 20 ° C to the boiling point of the reaction mixture; by saponification with an aqueous sodium hydroxide solution at a temperature of 20 to 25 ° C, and a compound of formula (I) as defined above R is released from the sodium salt solution by treatment with a mineral acid.
Kondensace thiomočoviny s látkami obecného vzorce XI, o výše uvedeném významu R, lze provádět i působením jiných silných basických činidel, avšak použití methylátu sodného přináší značné výhody z hlediska ekonomického, snadnosti manipulace a přípravy, oproti alkoholátům z vyšších alkoholů, nebo připravených za užití draslíku.The condensation of thiourea with compounds of formula XI, as defined above for R, can also be carried out by the action of other strong basic agents, but the use of sodium methylate provides considerable economic, ease of handling and preparation advantages over alcoholates from higher alcohols or potassium. .
Hydrolysa surového kondensátu vyžaduje použití mírných podmínek, vzhledem k možnosti průběhu vedlejších reakcí, včetně oxi dače. Látky obecného vzorce II, o výše uvedeném významu R, jsou sloučeniny z části známé a z části dosud nepopsané. Lze je všech ny připravit, většinou ve velmi dobrém výtěžku, stejnou methodou popsanou pro synthesu diethylesteru kyseliny 2-acetyl-1,7-heptan diové (Bourquin J.P. a sp.: Helv.Chim.Acta 28, 528 (1945)), tj. alkylací látek obecného vzorce III, r«go— ch2—cooc2h5 (III) ve kterém R má výše uvedený význam, ethyl- 5-brompentanoátem.Hydrolysis of the crude condensate requires the use of mild conditions due to the possibility of side reactions, including the oxidizer. The compounds of formula (II), as defined above for R, are in part known and in part not yet described. They can all be prepared, mostly in very good yield, by the same method described for the synthesis of diethyl 2-acetyl-1,7-heptanedioate (Bourquin JP et al .: Helv.Chim.Acta 28, 528 (1945)), ie alkylation of the compounds of formula III, R 2 -cococ 2 h 5 (III) wherein R is as defined above with ethyl 5-bromopentanoate.
Bližší podrobnosti o způsobu přípravy látek obecného vzorce I, o výše uvedeném významu R, vyplynou ž následujícího příkladu provedení.Further details of the process for the preparation of the compounds of formula (I), the meaning of R given above, will be apparent from the following example.
Kyselina 5-(2-merkapto-6-methyl-4-oxo~3,4-dihydropyrimidin-5-yl) pentanová5- (2-mercapto-6-methyl-4-oxo-3,4-dihydropyrimidin-5-yl) pentanoic acid
- 3 224 239- 3 224 239
K roztoku methylátu sodného, připraveného rozpuštěním 34,5 g (1,50 mol) sodíku v 500 ml methanolu, se při teplotě 40 až 45 °0 vnese za míchání 114,2 g (1,50 mol) thiomočoviny a pak 129,2 g (0,50 mol) diethylesteru kyseliny 2-acetyl-1,7-heptandiové. Reakční směs se míchá 4 hodiny přifcteplotě 20 až 25 °0 a pak se nechá stát při téže teplotě přes noc. Po oddestilování methanolu za sní* zeného tlaku (vodní pumpa) se odparek zmýdelní působením 1 1 0,5 S NaOH při teplotě 20 až 25 °C po dobu 2 hodin, zfiltruje se a filtrát se okyselí zředěnou kyselinou chlorovodíkovou (1:1) na pH 3. Vyloučená látka se po ochlazení odfiltruje, promyje vodou a vysuší. Získaná látka se přečistí krystalizací z vody. Teplota tání 243 až 245 °C.To a solution of sodium methylate prepared by dissolving 34.5 g (1.50 mol) of sodium in 500 ml of methanol at 40-45 ° C was charged with stirring 114.2 g (1.50 mol) of thiourea and then 129.2 g (0.50 mol) of 2-acetyl-1,7-heptanedioic acid diethyl ester. The reaction mixture was stirred at 20-25 ° C for 4 hours and then allowed to stand at the same temperature overnight. After distilling off the methanol under reduced pressure (water pump), the residue is saponified with 1 L of 0.5 S NaOH at 20-25 ° C for 2 hours, filtered and the filtrate acidified with dilute hydrochloric acid (1: 1) to pH 3. After cooling, the precipitate is filtered off, washed with water and dried. The material was purified by crystallization from water. Mp 243-245 ° C.
Stejným způsobem jak uvedeno v příkladu 1, za ušití odpovídarAV jících látek vzorce II, byly připletly následující sloučeniny: kyselina 5-(2-merkapto-6-pentyl-4-oxo-3,4-dihydropyrimidin-5-yl) pentanová, teplota tání 168 až 169 °C (ethanol) kyselina 5-(2-merkapto-6-heptyl-4-oxo-3,4-dihydropyrimidin-5-yl) pentanová, teplota tání 150 až 152 °C (ethanol+hexan) kyselina 5-(2-merkapto-6-benzyl-4-oxo-3,4-dihydropyrimidin-5-yl) pentanová, teplota tání 194 až 197 °C (50 % vodný ethanol) kyselina 5-(2-merkapto-6-fenyl-4-oxo-3,4-dihydropyrimidin-5-yl) pentanová, teplota tání 195 až i97 °0 (50 % vodný ethanol) kyselina 5-(2-merkapto-6-tolyl-4-oxo-3,4-dihydropyrimidin-5-yl) pentanová, teplota tání 147 až 149 °C (ethanol) kyselina 5-(2-merkapto-6-(3,4,5-trimethoxyfenyl)-4-oxo-3,4-dihydro pyrimidin- 5-yl) pentanová, teplota tání 202 až 204 °0 (vodný ethanol)In the same manner as in Example 1, using the corresponding compounds of Formula II, the following compounds were coupled: 5- (2-mercapto-6-pentyl-4-oxo-3,4-dihydropyrimidin-5-yl) pentanoic acid, temperature mp 168-169 ° C (ethanol) 5- (2-mercapto-6-heptyl-4-oxo-3,4-dihydropyrimidin-5-yl) pentanoic acid, m.p. 150-152 ° C (ethanol + hexane) acid 5- (2-mercapto-6-benzyl-4-oxo-3,4-dihydropyrimidin-5-yl) pentanoate, m.p. 194-197 ° C (50% aqueous ethanol) 5- (2-mercapto-6- phenyl-4-oxo-3,4-dihydropyrimidin-5-yl) pentanoic acid, m.p. 195-197 ° (50% aqueous ethanol) 5- (2-mercapto-6-tolyl-4-oxo-3,4) acid 147-149 ° C (ethanol) 5- (2-mercapto-6- (3,4,5-trimethoxyphenyl) -4-oxo-3,4-dihydro-pyrimidine-) 5-yl) pentane, m.p. 202-204 ° 0 (aqueous ethanol)
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS485682A CS224239B1 (en) | 1982-06-28 | 1982-06-28 | Method of preparing 6-substituted derivatives of 5-/2-mercapto-4-oxo-3,4-dihydropyrimidin-5-yl/pentanoic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS485682A CS224239B1 (en) | 1982-06-28 | 1982-06-28 | Method of preparing 6-substituted derivatives of 5-/2-mercapto-4-oxo-3,4-dihydropyrimidin-5-yl/pentanoic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS224239B1 true CS224239B1 (en) | 1984-01-16 |
Family
ID=5392234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS485682A CS224239B1 (en) | 1982-06-28 | 1982-06-28 | Method of preparing 6-substituted derivatives of 5-/2-mercapto-4-oxo-3,4-dihydropyrimidin-5-yl/pentanoic acid |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS224239B1 (en) |
-
1982
- 1982-06-28 CS CS485682A patent/CS224239B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU784777A3 (en) | Method of preparing purine derivatives or their salts | |
| GB1595337A (en) | Synthesis of methotrexate | |
| CS244408B2 (en) | Method of n-phosphonomethylglycine production | |
| US3562336A (en) | Synthesis of naphthalene derivatives | |
| KR890001825B1 (en) | Preparation of [(3-amino-3-carboxy) -propyl-1] phosphinic acid derivative | |
| EP0179254B1 (en) | 4,5-Dihydro-4-oxo-2- [(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof | |
| US6255492B1 (en) | Diesters of phosphoric acid 2,5-dioxo-4,4-diphenyl-imidazolidin-1-ylmethyl ester | |
| CS224239B1 (en) | Method of preparing 6-substituted derivatives of 5-/2-mercapto-4-oxo-3,4-dihydropyrimidin-5-yl/pentanoic acid | |
| US4937349A (en) | Process for the preparation of 3-[2'H-benzotriazol-(2')-yl]-4-hydroxy-benzenesulfonic acids and the salts thereof | |
| US4694103A (en) | Method of preparing N-acryloyl-α-amino acids | |
| IE41612B1 (en) | Triazolo isoquinoline derivatives | |
| HU213315B (en) | Process for producing arylacetic acids and their alkali metal salts | |
| US2948725A (en) | Flow sheet-process | |
| SU534182A3 (en) | Method for preparing sulfur-containing trialkoxybenzoylaminocarboxylic acid derivatives or their salts | |
| US4656309A (en) | Preparation of alpha-pivaloyl-substituted acetic acid esters | |
| JPH02273677A (en) | Method for producing 2-phenylbenzotriazoles | |
| Červinka et al. | Absolute configurations of some heterocyclic acids | |
| US4780542A (en) | Process for the synthesis of esters and amides of carboxylic acids | |
| PL105883B1 (en) | METHOD OF DISTRIBUTION OF THE MIXTURE FOR THE ALANINE-TYPE COMPOUND | |
| US4126639A (en) | Process for 11a-dehalogenation of 11a-halotetracyclines | |
| US4107179A (en) | Method for preparing ticrynafen | |
| Bickel | Diaryl Acetylenic Ketones | |
| US4354033A (en) | Anthranilic acid esters | |
| JP3899626B2 (en) | Preparation of 2-mercaptothiazol | |
| CS235166B1 (en) | 3-Anilino-1,5-dimethyl-4-pyrazolecarboxylic acid and its esters and processes for their preparation |